FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Review By Dilip Davda on July 3, 2023
• AIL is a digital technology company, operating in a highly competitive and fragmented segment.
• It has posted minuscule financial performance so far.
• Boosted profits for FY23 (two-broker periods) raise eyebrows.
• Based on FY23 super earnings, the issue is aggressively priced.
• There is no harm in skipping this pricey bet.
ABOUT COMPANY:
AccelerateBS India Ltd. (AIL) is a Digital Technology Services company offering a multitude of boutique technology services to both B2B and B2C companies around the world. Its services include Digital Technology Services, DXP (Digital Experience Platforms) Consulting and Implementation Services, Digital projects, custom software development and consulting services, and delivering powerful and scalable software systems.
It has built 100% in-house capabilities across DXP platforms like Crownpeak, Optimizely, Contentful and Strapi are some of the industry-leading enterprise DXP platforms that AIL specialize in. The company has full-spectrum capabilities across these platforms and this includes Front-end, Middleware, Backend, and DXP layers as well as custom integrations with products like Salesforce, Marketo, Brightcove, Adobe Omniture, SAP Commerce etc. It has full-stack Microsoft and Node-based capabilities and is engaged in doing new-age decoupled builds with API first and microservices-based architectures. As of January 31, 2023, it had 38 employees on its payroll.
ISSUE DETAILS/CAPITAL HISTORY:
The company is coming out with a maiden combo IPO of 632000 equity shares of Rs. 10 each at a fixed price of Rs.90 per share to mobilize Rs. 5.69 cr. It comprises of fresh equity issue of 188800 shares (worth Rs. 1.70 cr.) and an Offer for Sale (OFS) of 443200 shares (worth Rs. 3.99 cr. The issue opens for subscription on July 06, 2023, and will close on July 11, 2023. The minimum application to be made is for 1600 shares and in multiples thereon, thereafter. Post allotment, shares will be listed on BSE SME. The issue constitutes 29.41% of the post-issue paid-up capital of the company. AIL is spending Rs. 0.91 cr. for this IPO process (including Rs. 0.27 cr. for fresh equity issue), and from the net proceeds, it will utilize Rs. 1.09 cr. for working capital, and Rs. 0.34 cr. for general corporate purposes. The fresh equity issue is just around 30% of the total issue and the rest is by way of OFS. This indicates the promoter's exit at greedy pricing.
Shreni Shares Ltd. is the sole lead manager as well as the market maker and Bigshare Services Pvt. Ltd. is the registrar of the issue.
Having issued initial equity shares at par value, it issued further equity shares at a price of Rs. 100 per share in January 2023, and it has also issued bonus shares in the ratio of 3 for 2 in the same month. The average cost of acquisition of shares by the promoters is Rs. 9.18 per share.
Post-IPO, AIL's current paid-up equity capital of Rs. 1.96 cr. will stand enhanced to Rs. 2.15 cr. Based on the IPO pricing, the company is looking for a market cap of Rs. 19.34 cr.
FINANCIAL PERFORMANCE:
On the financial performance front, for the last three fiscals, AIL has posted a turnover/net profit of Rs. 4.93 cr. / Rs. 0.68 cr. (FY20), Rs. 4.52 cr. / Rs. 0.43 cr. (FY21), and Rs. 3.56 cr. / Rs. 0.26 cr. (FY22).
For the broken period of FY23, from April 01, 2022, to September 08, 2022, it posted a net profit of Rs. 0.33 cr. on a turnover of Rs. 1.83 cr. and from September 09, 2022, to January 31, 2023, it earned a net profit of Rs. 0.26 cr. on a turnover of Rs. 1.65 cr. Thus for 10M of FY23, it earned a net profit of Rs. 0.59 cr. on a turnover of Rs. 3.48 cr. Thus in a pre-IPO year, it posted an improved bottom line, which appears to be a window dressing. From FY20 to FY22 it marked a declining top line with inconsistent bottom lines.
For the last three fiscals, AIL has reported an average EPS of Rs. 3.82 (on pre-bonus and RI equity base) and an average RoNW of 46.98%. The issue is priced at a P/BV of 8.32 based on its NAV of Rs. 10.82 as of January 31, 2023, and at a P/BV of 5.56 based on its post-IPO NAV of Rs. 16.20 per share.
If we annualize FY23 super earnings and attribute it to post-IPO fully diluted paid-up equity capital then the asking price is at a P/E of 27.27 and on the basis of FY22 earnings, it stands at a P/E of 74.38. Thus the issue is priced aggressively.
DIVIDEND POLICY:
The company has not declared any dividends since incorporation. It will adopt a prudent dividend policy based on its financial performance and future prospects.
COMPARISON WITH LISTED PEERS:
As per the offer document, the company has shown Happiest Minds, Persistent Systems, Kellton Tech, Saksoft and CG-Vak as their listed peers. They are currently trading at a P/E of 66.78, 46.85, 72.03, 122.81, and 15.61 (as of July 03, 2023). While this comparison is a surprise, they are not truly comparable on an apple-to-apple basis.
MERCHANT BANKER'S TRACK RECORD:
This is the 19th mandate from Shreni Shares in the last three fiscals (including the ongoing one). Out of the last 10 listings, 1 opened at a discount and the rest listed at premiums ranging from 2.74% to 101.18% on the listing date.
Review By Dilip Davda on July 3, 2023
DISCLAIMER: No financial information whatsoever published anywhere here should be construed as an offer to buy or sell securities, or as advice to do so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. My reviews do not cover GMP market and operators game plans. Readers must consult a qualified financial advisor before making any actual investment decisions, based the on information published here. With entry barriers, SEBI wants only well-informed investors to participate in such offers. With crazy listings in the recent past, SME IPOs drew the attention of investors across the board and lead to seer madness. However, as SME issues have entry barriers and continued low preference from the broking community, any reader taking decisions based on any information published here does so entirely at their own risk. The above information is based on information available as of date coupled with market perceptions. The Author has no plans to invest in this offer.
About Dilip Davda
Dilip Davda is veteran journalist associated with stock market since 1978. He is contributing to print and electronic media on stock markets/insurance/finance since 1985.
Dilip Davda is a leading reviewer of public issues and NCDs in the primary stock market in India. The knowledge he gained over 3 decades while working in the stock market and a strong relationship with popular lead managers makes his reviews unique. His detail fundamental and financial analysis of companies coming up with IPO helps investors in the primary stock market. Dilip Davda has a special interest in analyzing the SME companies and writing reviews about their public issues. His reviews are regularly published online and in news papers.
(Dilip Davda -SEBI registered Research Analyst-Mumbai,
Registration no. INH000003127 (Perpetual)
Email id: dilip_davda@rediffmail.com ).
The initial public offer (IPO) of AccelerateBS India Limited offers an early investment opportunity in AccelerateBS India Limited. A stock market investor can buy AccelerateBS India IPO shares by applying in IPO before AccelerateBS India Limited shares get listed at the stock exchanges. An investor could invest in AccelerateBS India IPO for short term listing gain or a long term.
Read the AccelerateBS India IPO recommendations by the leading analyst and leading stock brokers.
AccelerateBS India IPO offers an opportunity to buy IPO shares before they get listed at the stock exchanges. Read the AccelerateBS India IPO Notes, Analysis and Recommendations by leading stock brokerage firms and experts in the above answer.
Our recommendation for AccelerateBS India IPO is to avoid.
As per the analysis by our lead analyst Mr. Dilip Davda, we suggest you to avoid the AccelerateBS India IPO.
The AccelerateBS India IPO allotment status will be available on or around July 14, 2023. The allotted shares will be credited in demat account by July 18, 2023. Visit AccelerateBS India IPO allotment status to check.
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|